Return to content in this issue

Successful isatuximab desensitization in a patient with refractory multiple myeloma and indolent systemic mastocytosis

Hutten EM¹, Roeloffzen WWH², Lambeck AJA³, van den Born-Bondt T⁴, Oude Elberink HNG¹, van de Ven AAJM<sup>1,5

1</sup>Department of Internal Medicine, division of Allergology, University Medical Center Groningen, Groningen, the Netherlands
²Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands
³Department of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands.
⁴Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, the Netherlands
⁵Department Rheumatology and Clinical Immunology, University Medical Center Groningen

J Investig Allergol Clin Immunol 2024; Vol. 34(3)
doi: 10.18176/jiaci.0990

• Abstract
• Supplemental Materials

Key words: Anaphylaxis, Isatuximab, Desensitization, Systemic mastocytosis

	Title	Type	Size
	doi10.18176_jiaci.0990_supplemental-materials-figure.pdf	pdf	147.60 Kb